Strontium ranelate: The first anti-osteoporotic agent to reduce the risk of vertebral fracture in patients with lumbar osteopenia

Seeman, E; Devogelaer, Jean-Pierre; Lorenc, RS; Spector, R; Brixen, K.; Vellas, B.; Balogh, A; Stucki, G; Meunier, PJ.; Reginster, Jacques

Strontium ranelate: The first anti-osteoporotic agent to reduce the risk of vertebral fracture in patients with lumbar osteopenia

Seeman, E

;

Devogelaer, Jean-Pierre

;

Lorenc, RS

;

Spector, R

;

Reginster, Jacques

;et.al.

(2004) IOF World Congress on Osteoporosis — Location: Rio de Janeiro (Brazil) (14.May.2004)

Files

No attached file found for this publication.

Details

Authors

Seeman, E
Author
Devogelaer, Jean-PierreUCLouvain
Author
Lorenc, RS
Author
Spector, R
Author
Reginster, JacquesUCLouvain
Author

Affiliations

UCLouvain

Citations

APA
Chicago
FWB

Seeman, E., Devogelaer, J.-P., Lorenc, R., Spector, R., Brixen, K., Vellas, B., Balogh, A., Stucki, G., Meunier, PJ., & Reginster, J. (2004). Strontium ranelate: The first anti-osteoporotic agent to reduce the risk of vertebral fracture in patients with lumbar osteopenia. Osteoporosis International : with other metabolic bone diseases, 15(6), 507-508. https://hdl.handle.net/2078.5/67774 (Original work published 2004)